Scientists from PGJCCR and the CRUK Scotland Institute have made a series of groundbreaking discoveries into tumour biology that may be used to deliver a more effective personalised medicine approach for patients with bowel (colorectal) cancer.
Researchers at Queen’s University Belfast and Patrick G Johnston Centre for Cancer Research (PGJCCR) have discovered a new method that could possibly improve the safety of radiotherapy for patients receiving treatment for lung cancer.
CV6 Therapeutics, based at the Patrick G. Johnston Centre for Cancer Research (PGJCCR), has received approval from the UK’s medicines regulator, the MHRA, to begin a UK-wide clinical trial for its first and novel anti-cancer drug called CV6-168.
The Patrick G Johnston Centre for Cancer Research (PGJCCR) has made history by launching Ireland’s first independent Prostate Cancer Centre of Excellence.
New all-island research led by Queen’s University Belfast and the Patrick G Johnston Centre for Cancer Research highlights the health and economic impact of the Good Friday Agreement on cancer across the island of Ireland in the last 25 years.
The donation from the Robin Menary Foundation will fund research into FLASH radiotherapy as a potential new method for the treatment of brain tumours.
A new study, the first of its kind, highlights the extent of gender inequality and gender bias against senior female academics working in cancer research in Europe.
Researchers from Patrick G Johnston Centre for Cancer Research have developed a new toolkit that harnesses the power of ‘Big Data’ for digital health with the aim of driving improvements in patient care and outcomes through data-driven innovation.
New research led by Queen’s University Belfast & the Patrick G Johnston Centre for Cancer Research has identified that the gene Spic plays a central role in regulating stem cell identity during early embryonic development.
Queen’s University Belfast hosted the Virtual Institute of Bioinformatics and Evolution, All-Ireland Conference 2023 (VIBE 2023) in May.
Queen’s University Belfast has a proud tradition in Cancer Research and its translation into improving the lives of our citizens, locally, nationally and internationally.
Congratulations to Dr Karl Butterworth from The Patrick G Johnston Centre for Cancer Research has won a highly prestigious international award from the Radiation Research Society in the United States.
Researchers at Queen’s University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.
Queen's has announced they are part of a consortium that will receive a multi-million-pound investment of government/industry funding to advance the use of artificial intelligence (AI) in cancer diagnosis and precision medicine.
In an article published this month in The Lancet Oncology, a collaborative team of international researchers led by Queen’s University Belfast, outlines the imperative for maintaining public trust in the use of health data for research.
Queen’s University Belfast will hosting AIMday Big Data, AI and the One Health Agenda on Friday 19th October 2018 at Riddel Hall, Queen’s University Belfast.
Early results from an innovative new clinical trial led by researchers from Queen’s University Belfast have shown that men with prostate cancer could benefit from radical radiotherapy that delivers treatment in just five visits.
A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.
A £10million Centre of Excellence in Precision Medicine was launched today by Invest Northern Ireland and Queen’s University Belfast.